Dr. Douglas Thamm – Flint Cancer Center, Colorado State University
Dr. Thamm is the Barbara Cox Anthony Professor of Oncology and Director of Clinical Research at the Colorado State University Flint Animal Cancer Center. He has authored over 200 peer-reviewed publications and 25 book chapters in veterinary and basic cancer research, is Co-Editor for the most recent edition of the textbook Withrow and MacEwen’s Small Animal Clinical Oncology, and is Editor-In-Chief of the journal Veterinary and Comparative Oncology. Dr. Thamm is the President of the Veterinary Cancer Society and the 2025 recipient of the Alan Kelly International Prize in Canine Health from The Kennel Club.
Christina Ip-Toma – Director of Scientific Program, MIB Agents Osteosarcoma Alliance
Christina’s son Dylan was diagnosed with osteosarcoma in 2016. When Dylan passed away in 2021 after bravely battling osteosarcoma for five years, Christina joined the MIB Agents team in January 2022 as the Director of Scientific Programs. In this role, Christina creates programs to engage and support the scientific community that is striving to improve treatment options and outcomes. Before focusing on patient advocacy, Christina had a career in advertising, with experience at a traditional advertising agency and building advertising programs at search engines like Excite and Google. In addition to being a proud owner of a MIB Agents Family Fund honoring Dylan, she is also a founding member of the Battle Osteosarcoma team that has partnered with St. Baldrick’s Foundation to fund over $3 million in osteosarcoma research grants since 2019. She is honored to serve as a consumer reviewer for the CDMRP Peer Review Cancer Research and Rare Cancer Research Programs, as a member of the Count Me In Osteosarcoma Stakeholder Advisory Group, and as a Research Advocate on the NCI Human Tumor Atlas Network (HTAN) Steering Committee as a member of the NCI Office of Advocacy Relations advocate network. She is grateful to MIB Agents and these programs for giving her the opportunity to make it better for OsteoWarriors and pediatric cancer patients everywhere, which is helping her transform senseless loss into a sense of purpose – #BecauseOfDylan.